drugset / Trial / NCT00229125

Comparing the Treatment of Alcohol Withdrawal Syndrome Using Gabapentin Versus Lorazepam

NCT00229125

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study was to evaluate if the medication Gabapentin, which is not approved for the treatment of alcohol withdrawal, is effective in the treatment of alcohol withdrawal syndrome compared to treatment with Lorazepam.

Timeline

Start
2001-07
Primary completion
Completion
2005-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule
Subject Lorazepam Small molecule

Indications